On Invalid Date, Reneo Pharmaceuticals (NASDAQ: RPHM) reported Q1 2023 earnings per share (EPS) of -$0.60, up 13.21% year over year. Total Reneo Pharmaceuticals earnings for the quarter were -$15.11 million. In the same quarter last year, Reneo Pharmaceuticals's earnings per share (EPS) was -$0.53.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.